Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 70

Sort by

Sort Order Select

Journal Articles

Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis

Laurent Martin, Darko Maric, Salam Idriss, Marine Delamare, Amandine Le Roy, Nada Maaziz, Amandine Caillaud, Karim Si-Tayeb, Florence Robriquet, Marion Lenglet, Lucie Erceau, Christine Bellanné-Chantelot, Isabelle Plo, Bernard Aral, Céline Garrec, Fabrice Airaud, Clara Gianfermi, Vincent Antunes, Anna Keppner, Sarah Mathilda Vincent, Alexis Desfontaine, Nina Modé, Fabien Laporte, Anne Gaignerie, Caroline Chariau, Isabelle Leray, Coline Rogue, Laurent David, Richard Redon, Stephane Bezieau, Lamisse Mansour, Frederic Galacteros, Thibault Maillet, Marlène Pasquet, Pierre Cougoul, Anne-Marie Nloga, Claude Gardin, Corinne Guitton, Viviane Dubruille, Vannina Giacobbi-Milet, Thierry Leblanc, Zuhre Kaya, Denis Semama, Chloe James, Serge Carillo, Marlène Ochmann, Anders Waage, Erwan Mortier, Mike Maillasson, Agnès Quéméner, Holger Cario, Radek C. Skoda, Yaël Zermati, David Hoogewijs, Alexandre Marchand, Francois Girodon, Betty Gardie

Blood (2024) 144 (Supplement 2): LBA-2.

https://doi.org/10.1182/blood-2024-213000

Published: 2024

Journal Articles

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Blood (2024) 144 (Supplement 1): 794.

https://doi.org/10.1182/blood-2024-201501

Published: 2024

Journal Articles

Unique Nature of Sickle Cell Diastolic Cardiomyopathy: A Tailored Echocardiographic Definition to Refine Prognostic Stratification in Young Adults

Thomas D'Humieres, Théo Simon, Kristoffer Grundtvig Skaarup, Laurent Savale, Paul Breillat, Jocelyn Inamo, Gylna Loko, Christelle Chantalat-Auger, Anne-Laure Pham Hung D'Alexandry D'Orengiani, Anoosha Habibi, Gonzalo De Luna, Niklas Dyrby Johansen, François Lionnet, Frederic Galacteros, Etienne Audureau, Mark T. Gladwin, Tor Biering-Sørensen, Geneviève Derumeaux, Pablo Bartolucci

Blood (2024) 144 (Supplement 1): 3891.

https://doi.org/10.1182/blood-2024-208896

Published: 2024

Journal Articles

In silico and Functional Studies for Classification of EPAS1/HIF2A Genetic Variants Identified in Patients with Erythrocytosis

Valéna Karaghiannis, Darko Maric, Céline Garrec, Nada Maaziz, Alexandre Buffet, Vincent Antunes, Amandine le Roy, Fabrice Airaud, Bernard Aral, Loic Schmitt, Sébastien Corbineau, Lamisse Mansour-Hendili, Valentine Lesieur, Antoine Rimbert, Fabien Laporte, Marine Delamare, Stephane Bezieau, Bruno Cassinat, Frédéric Galactéros, Anne-Paule Gimenez-Roqueplo, Nelly Burnichon, Holger Cario, Richard van Wijk, Celeste Bento, Anaise Blouet, Juliette Bouteloup, Françoise Boyer perrard, Aisha Aiko Bruce, Emilie Cayssials, Nicole Casadevall, Brieuc Cherel, Marielaure Couec, Louis Drevon, Cecile Dumesnil, Thierry Lamy De La Chapelle, Marion Gambart, Loic Garcon, Brigitte Granel, Pierre Hirsch, Agnès Lahary, Amira Mejri, Sandrine Meunier, Franck E. Nicolini, Emmanuel Raffoux, Dana Ranta, Nicolas Schleinitz, Jean Baptiste Valentin, Mathieu Wemeau, Francois Girodon, David Hoogewijs, Betty Gardie, Olivier Hermine

Blood (2022) 140 (Supplement 1): 8157–8158.

https://doi.org/10.1182/blood-2022-163123

Published: 2022

Journal Articles

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Blood (2022) 140 (Supplement 1): 5313–5315.

https://doi.org/10.1182/blood-2022-169125

Published: 2022

Journal Articles

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Mariane de Montalembert, Frédéric Galactéros, Lena Oevermann, Giovanna Cannas, Laure Joseph, Gylna Loko, Narcisse Elenga, Malika Benkerrou, Maryse Etienne-Julan, Marie-Pierre Castex, Regine Grosse, Valentine Brousse

Blood (2022) 140 (Supplement 1): 449–450.

https://doi.org/10.1182/blood-2022-165946

Published: 2022

Journal Articles

Impact of Transfusion Program during Pregnancy on the Obstetrical Outcomes in Sickle Cell Disease Women

Anoosha Habibi, Marion Lefebvre, Octavia Sobcyk, Florence Canouï-Poitrine, Amna Jebali, Gonzalo De Luna, Pablo Bartolucci, Frédéric Galactéros, France Pirenne, Diane Redel, Emmanuelle Boutin, Bassam Haddad, Edouard Lecarpentier

Blood (2022) 140 (Supplement 1): 8312–8313.

https://doi.org/10.1182/blood-2022-160111

Published: 2022

Journal Articles

Clonal hematopoiesis in sickle cell disease

Thomas Pincez, Simon S. K. Lee, Yann Ilboudo, Michael Preuss, Anne-Laure Pham Hung d’Alexandry d’Orengiani, Pablo Bartolucci, Frédéric Galactéros, Philippe Joly, Daniel E. Bauer, Ruth J. F. Loos, R. Coleman Lindsley, Guillaume Lettre

Blood (2021) 138 (21): 2148–2152.

https://doi.org/10.1182/blood.2021011121

Published: 2021

Includes: Supplemental data

Journal Articles

Causes and Circumstances of Death: Analysis in 266 Sickle Cell Adult Patients

Anoosha Habibi, Stephanie Ngo, Keyvan Razazi, Vincent Audard, Gonzalo De Luna, Marc Michel, France Pirenne, Henri Guillet, Christian Kassasseya, Frédéric Galactéros, Armand Mekontso-Dessap, Pablo Bartolucci

Blood (2021) 138 (Supplement 1): 974.

https://doi.org/10.1182/blood-2021-149761

Published: 2021

Journal Articles

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Mariane de Montalembert, Ersi Voskaridou, Lena Oevermann, Giovanna Cannas, Anoosha Habibi, Gylna Loko, Laure Joseph, Raffaella Colombatti, Pablo Bartolucci, Valentine Brousse, Frédéric Galactéros

Blood (2021) 138 (Supplement 1): 3098.

https://doi.org/10.1182/blood-2021-152525

Published: 2021

Journal Articles

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Blood (2021) 138 (Supplement 1): 848.

https://doi.org/10.1182/blood-2021-147711

Published: 2021

Journal Articles

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Hanny Al-Samkari, Rachael F. Grace, Andreas Glenthoej, Oliver Andres, Wilma Barcellini, Frédéric Galactéros, Kevin H.M. Kuo, D. Mark Layton, Marta Morado, Vip Viprakasit, Yan Dong, Feng Tai, Liz Grekas, Karishma Khoja, Sarah Gheuens, Bryan McGee, John B. Porter, Eduard J. Van Beers

Blood (2021) 138 (Supplement 1): 924.

https://doi.org/10.1182/blood-2021-147156

Published: 2021

Journal Articles

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Frédéric Galactéros, MDPhD, Ersi Voskaridou, Anoosha Habibi, MD PhD, Giovanna Cannas, MD, Laure Joseph, MD, Gylna Loko, MD, Mariane De Montalembert, MD PhD, Narcisse Elenga, MD PhD, Malika Benkerrou, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-140265

Published: 2020

Journal Articles

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

Hanny Al-Samkari, MD, Rachael F. Grace, MD, Andreas Glenthoej, MD, Oliver Andres, MD, Wilma Barcellini, Frédéric Galactéros, MDPhD, Kevin H.M. Kuo, MDMSc,FRCPC, D. Mark Layton, MB BS, Marta Morado, PhD, Vip Viprakasit, Yan Dong, PhD, Feng Tai, PhD, Peter Hawkins, PhD, Sarah Gheuens, MD PhD, Chris Bowden, MD, John B. Porter, MA, MD, FRCP, FRCPath, Eduard van Beers, MD PhD

Blood (2020) 136 (Supplement 1): 30–32.

https://doi.org/10.1182/blood-2020-136598

Published: 2020

Journal Articles

A new gene associated with a β-thalassemia phenotype: the observation of variants in SUPT5H

Blood (2020) 136 (15): 1789–1793.

https://doi.org/10.1182/blood.2020005934

Published: 2020

Includes: Supplemental data

Journal Articles

Beneficial effects of endurance exercise training on skeletal muscle microvasculature in sickle cell disease patients

Angèle N. Merlet, Laurent A. Messonnier, Cécile Coudy-Gandilhon, Daniel Béchet, Barnabas Gellen, Thomas Rupp, Frédéric Galactéros, Pablo Bartolucci, Léonard Féasson

Blood (2019) 134 (25): 2233–2241.

https://doi.org/10.1182/blood.2019001055

Published: 2019

Includes: Supplemental data

Journal Articles

Sickle-Cell Disease Patients' Attitudes Towards Their Treatment with Hydroxycarbamide

Frédéric Galactéros, MD PhD, Ersi Voskaridou, Anoosha Habibi, Giovanna Cannas, MD, Laure Joseph, MD, Stephanie Ngo, MD, Nathalie Lemonne, Emmanuelle Bernit, MD, Justine Gellen-Dautremer, MD, Gylna Loko, MD

Blood (2019) 134 (Supplement_1): 1013.

https://doi.org/10.1182/blood-2019-125673

Published: 2019

Journal Articles

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Nicolas Hebert, Rakotoson Marie Georgine, PhD, Gwellaouen Bodivit, Etienne Audureau, MD PhD, Nadia Oubaya, Sadaf Pakdaman, Mehdi Sakka, Gaetana Di Liberto, PhD, Philippe Chadebech, PhD, Benoît Vingert, PhD, France Pirenne, MD PhD, Frédéric Galactéros, MD PhD, Marie Cambot, PhD, Pablo Bartolucci, MD PhD

Blood (2019) 134 (Supplement_1): 1008.

https://doi.org/10.1182/blood-2019-126727

Published: 2019

Journal Articles

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Fabian Zanchetta-Balint, France Pirenne, MD PhD, Marc Michel, Armand Mekontso-Dessap, MD PhD, Matthieu Mahevas, MD, Constance Guillaud, MD, Keyvan Razazi, MD, Elena Foïs, MD, Frédéric Galactéros, MD PhD, Pablo Bartolucci, MD PhD, Anoosha Habibi

Blood (2019) 134 (Supplement_1): 3687.

https://doi.org/10.1182/blood-2019-130874

Published: 2019

Journal Articles

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Rachael F. Grace, MD, D. Mark Layton, MB BS, FRCP, FRCPCH, Frédéric Galactéros, MD PhD, Wilma Barcellini, MD, Eduard J. van Beers, MD PhD, Hassan M. Yaish, MD, Yaddanapudi Ravindranath, MBBS, Kevin H. M. Kuo, MDMSc,FRCPC, Sujit Sheth, MD, Janet L. Kwiatkowski, MD MSCE, Lei Hua, PhD, Peter F. Hawkins, PhD, Chris Mix, MD, Bertil Glader, MD PhD

Blood (2019) 134 (Supplement_1): 3512.

https://doi.org/10.1182/blood-2019-123406

Published: 2019

NARROW

Identification of Hepatic-like Erythropoietin with Enhanced Activity As a New Cause of Hereditary and Acquired Erythrocytosis

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Unique Nature of Sickle Cell Diastolic Cardiomyopathy: A Tailored Echocardiographic Definition to Refine Prognostic Stratification in Young Adults

In silico and Functional Studies for Classification of EPAS1/HIF2A Genetic Variants Identified in Patients with Erythrocytosis

Long-Term Hemoglobin Response and Reduction in Transfusion Burden Are Maintained in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat

Hydroxyurea Is Associated with Later Onset of Occurrence of Acute Splenic Sequestration Episodes in Sickle Cell Disease: Lessons from the European Sickle Cell Disease Cohort - Hydroxyurea (ESCORT-HU) Study

Impact of Transfusion Program during Pregnancy on the Obstetrical Outcomes in Sickle Cell Disease Women

Clonal hematopoiesis in sickle cell disease

Causes and Circumstances of Death: Analysis in 266 Sickle Cell Adult Patients

Implementation of Escort-HU Extension: European Sickle Cell Disease Cohort - Hydroxyurea - Extension Study : Interests and Methodology

Durability of Hemoglobin Response and Reduction in Transfusion Burden Is Maintained over Time in Patients with Pyruvate Kinase Deficiency Treated with Mitapivat in a Long-Term Extension Study

Bone Mineral Density Remains Stable in Pyruvate Kinase Deficiency Patients Receiving Long-Term Treatment with Mitapivat

Is There a Clinical Benefit to Switch Hydroxyurea (HU) Drug in Sickle Cell Disease (SCD)?

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

A new gene associated with a β-thalassemia phenotype: the observation of variants in SUPT5H

Beneficial effects of endurance exercise training on skeletal muscle microvasculature in sickle cell disease patients

Sickle-Cell Disease Patients' Attitudes Towards Their Treatment with Hydroxycarbamide

Fetal Hemoglobin Measurement per Red Blood Cell Provides Biological and Clinical Protective Thresholds

Rituximab for Preventing Delayed Hemolytic Transfusion Reaction (DHTR) in Sickle CELL Adult Patients: Outcome of Transfusion and SIDE Effects in 58 CASES

Long-Term Safety and Efficacy of Mitapivat (AG-348), a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency: The DRIVE PK Study

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only